Population Pharmacokinetics and Adverse Events of Erlotinib in Japanese Patients with Non-small-cell Lung Cancer: Impact of Genetic Polymorphisms in Metabolizing Enzymes and Transporters
BIOLOGICAL & PHARMACEUTICAL BULLETIN（2018）
Key words
erlotinib,population pharmacokinetics,genetic polymorphism,adverse event
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined